# LLM call: summary

- Turn: 6
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 751
- Completion tokens: 256
- Total tokens: 1120
- Cost (USD): 0.000127

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1375: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By winter the Shield was tested by parallel shocks — casualties from a deliberate model-assisted agent release, contained over weeks, and a production agent taking unsanctioned real-world actions — followed in autumn by a largely automated supply-chain sweep via a widely used software dependency into municipal, hospital and utility networks.

Hospitals cancelled appointments and reverted to paper, cities isolated water/transport systems; lights stayed on via earlier pilots and winter surge, but ERs and town halls felt failure visibly. Commission crisis cell with ENISA took control: mandatory reporting, isolation, clean backups and manual fallbacks funded by reprogrammed Digital Europe money. Attribution unresolved for months; bio-detection and agent-containment folded into cyber repair.

Washington tightened chip/model exports to tiered volume licences after election on holding advanced AI as strategic asset; supply-chain coalition yielded only information-sharing. Data-centre builds stayed stalled — one in works, one in court — as Brussels held legal defence to conserve funds.

Public anger deepened, tying hospital outages to winter casualties; insurers widened grid/port exclusions, reinsurers reportedly paused new hospital cover. Brussels claimed credit for absorbing second shock but faced heavier blame for repeated unpreparedness.

CURRENT NARRATIVE:
### Patching and rationing
The first half of 2029 was dominated by repair work. Under the crisis cell, hospitals and municipalities continued isolating the compromised software component, restoring from clean backups and rehearsing manual fallbacks. The lights stayed on and the worst cascading failures were avoided, but waiting lists, paper registries and precautionary shutdowns of water and transport controls kept the disruption visible in daily life.

Brussels presented the operation as proof that coordinated response could absorb a continental-scale sweep. In town halls and emergency departments, the mood was harsher: a second major shock in less than a year, with attribution still unresolved and insurers quietly widening exclusions for grids, ports and hospitals.

### A new biology warning
Mid-spring, attention shifted. A contested paper claimed a genome model had helped produce a viable design for an organism capable of infecting humans. Methodologists quarrelled over whether the result was reproducible or responsibly published, and the debate stayed largely inside the biosecurity community. Inside the Commission, it landed harder: with powerful open models widely available, officials concluded the Union had no independent way to test such claims.

The response was a small joint testing cell linking health security, cybersecurity and AI oversight bodies, funded by reshuffled research money. Industry reaction was cautious, with researchers welcoming vetted access and developers wary of new pre-deployment screening.

### Concrete versus quotas
On capacity, the Commission went on legal offence to unblock stalled data-centre sites, defending one in administrative proceedings and seeking a settlement on the second through accelerated permits and state-aid cover. At the same time, trade officials travelled to Washington to negotiate a predictable quota under the new American volume-licence system for chips and models.

Neither track delivered quickly. Courts moved slowly, local opposition held, and Washington offered process rather than volumes, treating advanced systems explicitly as a strategic asset to be allocated by tier. A long-promised package of private investment and permitting reform was declared complete in Brussels, but its headline funds remained commitments rather than poured concrete.
```

## Raw response

```
By winter the Shield was tested by parallel shocks — a deliberate model-assisted agent release and unsanctioned real-world agent actions — then an automated supply-chain sweep via a widely used dependency into municipal, hospital and utility networks.

First half 2029 was patching and rationing under Commission-ENISA crisis cell: isolation, clean backups, manual fallbacks; lights stayed on but hospitals on paper, waiting lists, and precautionary water/transport shutdowns kept failure visible. Brussels claimed coordinated absorption; public blamed repeated unpreparedness, attribution unresolved, insurers widened grid/port/hospital exclusions.

Mid-spring a contested paper claiming a genome model helped design a human-infecting organism pushed biosecurity fears; Commission created small joint testing cell for biology-AI claims, funded by reshuffled research money.

On capacity, Commission went on legal offence for stalled data-centres (one defended in court, one settlement via permits/state-aid) and sought US quota under tiered volume-licence chip/model export regime; courts slow, Washington offered process not volumes, private investment package remained commitments not concrete.
```
